Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas

BACKGROUND: We conducted a phase I study to estimate the maximum tolerated dose and describe the dose-limiting toxicities and pharmacokinetics of oral capecitabine rapidly disintegrating tablets given concurrently with radiation therapy to children with newly diagnosed brainstem or high-grade glioma...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kilburn, Lindsay B., Kocak, Mehmet, Schaedeli Stark, Franziska, Meneses-Lorente, Georgina, Brownstein, Carrie, Hussain, Sazzad, Chintagumpala, Murali, Thompson, Patrick A., Gururangan, Sri, Banerjee, Anuradha, Paulino, Arnold C., Kun, Larry, Boyett, James M., Blaney, Susan M.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2013
Sujets:
Clinical Investigations
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3661085/
https://ncbi.nlm.nih.gov/pubmed/23592571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nos315
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires